SOLUBLE PROGRAMMED CELL DEATH-1 IN PSORIASIS AND PSORIATIC ARTHRITIS PATIENTS

被引:0
|
作者
Tabra, S. A. A. [1 ]
Elsharaby, R. [2 ]
Shaker, E. S. E. [3 ]
Moustafa, A. A. [4 ]
Abu-Zaid, M. H. [1 ]
机构
[1] Tanta Univ, Rheumatol & Rehabil, Fac Med, Tanta, Egypt
[2] Tanta Univ, Clin Pathol, Fac Med, Tanta, Egypt
[3] Tanta Univ, Dermatol & Venereol, Fac Med, Tanta, Egypt
[4] Al Azhar Univ, Rheumatol & Rehabil, New Damietta Branch, Dumyat, Egypt
关键词
Psoriatic arthritis;
D O I
10.1136/annrheumdis-2023-eular.399
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB1155
引用
收藏
页码:1807 / 1807
页数:1
相关论文
共 50 条
  • [1] Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis
    Michael Peled
    Marianne Strazza
    Inbar Azoulay-Alfaguter
    Adam Mor
    Inflammation, 2015, 38 : 1573 - 1579
  • [2] Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis
    Peled, Michael
    Strazza, Marianne
    Azoulay-Alfaguter, Inbar
    Mor, Adam
    INFLAMMATION, 2015, 38 (04) : 1573 - 1579
  • [3] Erratum to: Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis
    Michael Peled
    Marianne Strazza
    Inbar Azoulay-Alfaguter
    Gregg J. Silverman
    Jose U. Scher
    Adam Mor
    Inflammation, 2015, 38 : 1580 - 1580
  • [4] Targeting the programmed cell death-1 pathway in rheumatoid arthritis
    Sandigursky, Sabina
    Silverman, Gregg J.
    Mor, Adam
    AUTOIMMUNITY REVIEWS, 2017, 16 (08) : 767 - 773
  • [5] Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
    Tominaga, Tetsuro
    Akiyoshi, Takashi
    Yamamoto, Noriko
    Taguchi, Senzo
    Mori, Seiichi
    Nagasaki, Toshiya
    Fukunaga, Yosuke
    Ueno, Masashi
    PLOS ONE, 2019, 14 (02):
  • [6] Prognostic value of soluble programmed death-1 and soluble programmed death ligand-1 in severe traumatic brain injury patients
    Liu, Lei
    Lan, Pengpeng
    Wu, Guiping
    Zhu, Xiaojie
    Shi, Hongfeng
    Li, Yan
    Li, Ruili
    Zhao, Ling
    Xu, Juan
    Xu, Min
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] The Analysis of the Soluble Programmed Death-1 of Lung Cancer Patients with Different Characteristics
    Zhu, H.
    Tian, R.
    Guo, W.
    Guo, Y.
    Xu, J.
    Song, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S700 - S701
  • [8] Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity
    Niedzwiedzka-Rystwej, Paulina
    Majchrzak, Adam
    Aksak-Was, Bogusz
    Serwin, Karol
    Czajkowski, Zenon
    Grywalska, Ewelina
    Korona-Glowniak, Izabela
    Rolinski, Jacek
    Parczewski, Milosz
    CELLS, 2022, 11 (12)
  • [9] Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients
    Tahoori, M. T.
    Pourfathollah, A. A.
    Akhlaghi, M.
    Daneshmandi, S.
    Nicknam, M. H.
    Soleimanifar, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (05) : 763 - 767
  • [10] Programmed cell death-1 inhibition in lymphoma
    Hawkes, Eliza A.
    Grigg, Andrew
    Chong, Geoff
    LANCET ONCOLOGY, 2015, 16 (05): : E234 - E245